REFERENCES
- Creemers E. E., Cleutjens J. P., Smits J. F., Daemen M. J.. 2001. Matrix metalloproteinase inhibition after myocardial infarction: A new approach to prevent heart failure?. Circ. Res.. 89: 201–210. [PUBMED], [INFOTRIEVE]
- Murphy G., Knauper V., Atkinson S., Butler G., English W., Hutton M., Stracke J., Clark I.. 2002. Matrix metalloproteinases in arthritic disease. Arthritis. Res.. 4(Suppl 3)S39–49. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ortega N., Behonick D., Stickens D., Werb Z.. 2003. How proteases regulate bone morphogenesis. Ann. N Y Acad. Sci.. 995: 109–116. [PUBMED], [INFOTRIEVE], [CSA]
- Nabeshima K., Inoue T., Shimao Y., Sameshima T.. 2002. Matrix metalloproteinases in tumor invasion: Role for cell migration. Pathol. Int.. 52: 255–264. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rosenberg G. A.. 2002. Matrix metalloproteinases in neuroinflammation. Glia. 39: 279–291. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lenz O., Elliot S. J., Stetler-Stevenson W. G.. 2000. Matrix metalloproteinases in renal development and disease. J. Am. Soc. Nephrol.. 11: 574–581. [PUBMED], [INFOTRIEVE], [CSA]
- George S. J.. 1998. Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis. Curr. Opin. Lipidol.. 9: 413–423. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Galis Z. S., Khatri J. J.. 2002. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ. Res.. 90: 251–262. [PUBMED], [INFOTRIEVE]
- Nagase H., Woessner J. F., Jr.. 1999. Matrix metalloproteinases. J. Biol. Chem.. 274: 21491–21494. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pohl M., Sakurai H., Bush K. T., Nigam S. K.. 2000. Matrix metalloproteinases and their inhibitors regulate in vitro ureteric bud branching morphogenesis. Am. J. Physiol. Renal. Physiol.. 279: F891–900. [PUBMED], [INFOTRIEVE], [CSA]
- Davies J.. 2001. Intracellular and extracellular regulation of ureteric bud morphogenesis. J. Anat.. 198: 257–264. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Horster M. F., Braun G. S., Huber S. M.. 1999. Embryonic renal epithelia: Induction, nephrogenesis, and cell differentiation. Physiol. Rev.. 79: 1157–1191. [PUBMED], [INFOTRIEVE], [CSA]
- Saxen L.. 1987; Organogenesis of the Kidney. New York, Cambridge University Press
- Birkedal-Hansen H.. 1995. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol.. 7: 728–735. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sternlicht M. D., Werb Z.. 2001. How matrix metalloproteinases regulate cell behavior. Ann. Rev. Cell Dev. Biol.. 17: 463–516. [CSA], [CROSSREF]
- Gomez D. E., Alonso D. F., Yoshiji H., Thorgeirsson U. P.. 1997. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur. J. Cell Biol.. 74: 111–122. [PUBMED], [INFOTRIEVE]
- Gomis-Ruth F. X., Maskos K., Betz M., Bergner A., Huber R., Suzuki K., Yoshida N., Nagase H., Brew K., Bourenkov G. P., Bartunik H., Bode W.. 1997. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature. 389: 77–81. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Baker A. H., Edwards D. R., Murphy G.. 2002. Metalloproteinase inhibitors: Biological actions and therapeutic opportunities. J. Cell Sci.. 115: 3719–3727. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brew K., Dinakarpandian D., Nagase H.. 2000. Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim. Biophys. Acta. 1477: 267–283. [PUBMED], [INFOTRIEVE]
- Yu A. E., Hewitt R. E., Connor E. W., Stetler-Stevenson W. G.. 1997. Matrix metalloproteinases. Novel targets for directed cancer therapy. Drugs Aging. 11: 229–244. [PUBMED], [INFOTRIEVE], [CSA]
- Werb Z.. 1997. ECM and cell surface proteolysis: Regulating cellular ecology. Cell. 91: 439–442. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vu T. H., Werb Z.. 2000. Matrix metalloproteinases: Effectors of development and normal physiology. Genes Dev.. 14: 2123–2133. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Massova I., Kotra L. P., Fridman R., Mobashery S.. 1998. Matrix metalloproteinases: Structures, evolution, and diversification. FASEB J.. 12: 1075–1095. [PUBMED], [INFOTRIEVE], [CSA]
- Marti H. P.. 2000. Role of matrix metalloproteinases in mesangial proliferative glomerulonephritis. Kidney Blood Press. Res.. 23: 199–201. [PUBMED], [INFOTRIEVE], [CSA]
- Visse R., Nagase H.. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ. Res.. 92: 827–839. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pei D., Kang T., Qi H.. 2000. Cysteine array matrix metalloproteinase (CA-MMP)/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation. J. Biol. Chem.. 275: 33988–33997. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Van, Wart H. E., Birkedal-Hansen H.. 1990. The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA. 87: 5578–5582. [PUBMED], [INFOTRIEVE], [CSA]
- Gu Z., Kaul M., Yan B., Kridel S. J., Cui J., Strongin A., Smith J. W., Liddington R. C., Lipton S. A.. 2002. S-nitrosylation of matrix metalloproteinases: Signaling pathway to neuronal cell death. Science. 297: 1186–1190. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lijnen H. R.. 2001. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb. Haemost.. 86: 324–333. [PUBMED], [INFOTRIEVE], [CSA]
- Sato H., Kinoshita T., Takino T., Nakayama K., Seiki M.. 1996. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett.. 393: 101–104. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pei D., Weiss S. J.. 1995. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature. 375: 244–247. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Marchenko G. N., Strongin A. Y.. 2001. MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors. Gene. 265: 87–93. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nagase H.. 1997. Activation mechanisms of matrix metalloproteinases. Biol. Chem.. 378: 151–160. [PUBMED], [INFOTRIEVE], [CSA]
- Chung L., Shimokawa K., Dinakarpandian D., Grams F., Fields G. B., Nagase H.. 2000. Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity. J. Biol. Chem.. 275: 29610–29617. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Murphy G., Nguyen Q., Cockett M. I., Atkinson S. J., Allan J. A., Knight C. G., Willenbrock F., Docherty A. J.. 1994. Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J. Biol. Chem.. 269: 6632–6636. [PUBMED], [INFOTRIEVE]
- Shipley J. M., Doyle G. A., Fliszar C. J., Ye Q. Z., Johnson L. L., Shapiro S. D., Welgus H. G., Senior R. M.. 1996. The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J. Biol. Chem.. 271: 4335–4341. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Allan J. A., Docherty A. J., Barker P. J., Huskisson N. S., Reynolds J. J., Murphy G.. 1995. Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem. J.. 309(Pt 1)299–306. [PUBMED], [INFOTRIEVE]
- Patterson M. L., Atkinson S. J., Knauper V., Murphy G.. 2001. Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain. FEBS Lett.. 503: 158–162. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kanwar Y. S., Ota K., Yang Q., Wada J., Kashihara N., Tian Y., Wallner E. I.. 1999. Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis. Am. J. Physiol.. 277: F934–947. [PUBMED], [INFOTRIEVE]
- Wang Z., Juttermann R., Soloway P. D.. 2000. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J. Biol. Chem.. 275: 26411–26415. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hernandez-Barrantes S., Bernardo M., Toth M., Fridman R.. 2002. Regulation of membrane type-matrix metalloproteinases. Semin. Cancer. Biol.. 12: 131–138. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Seiki M.. 1999. Membrane-type matrix metalloproteinases. APMIS. 107: 137–143. [PUBMED], [INFOTRIEVE], [CSA]
- Ota K., Stetler-Stevenson W. G., Yang Q., Kumar A., Wada J., Kashihara N., Wallner E. I., Kanwar Y. S.. 1998. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor. Kidney Int.. 54: 131–142. [PUBMED], [INFOTRIEVE]
- Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M.. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370: 61–65. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pei D.. 1999. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J. Biol. Chem.. 274: 8925–8932. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Saarialho-Kere U., Kerkela E., Jahkola T., Suomela S., Keski-Oja J., Lohi J.. 2002. Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair. J. Invest. Dermatol.. 119: 14–21. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lohi J., Wilson C. L., Roby J. D., Parks W. C.. 2001. Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J. Biol. Chem.. 276: 10134–10144. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shipley J. M., Wesselschmidt R. L., Kobayashi D. K., Ley T. J., Shapiro S. D.. 1996. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc. Natl. Acad. Sci. USA. 93: 3942–3946. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yang M., Kurkinen M.. 1998. Cloning and characterization of a novel matrix metalloproteinase (MMP), CMMP, from chicken embryo fibroblasts. CMMP, Xenopus XMMP, and human MMP19 have a conserved unique cysteine in the catalytic domain. J. Biol. Chem.. 273: 17893–17900. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kuure S., Vuolteenaho R., Vainio S.. 2000. Kidney morphogenesis: Cellular and molecular regulation. Mech. Dev.. 92: 31–45. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Saxen L., Lehtonen E.. 1987. Embryonic kidney in organ culture. Differentiation. 36: 2–11. [PUBMED], [INFOTRIEVE]
- Vize P. D., Seufert D. W., Carroll T. J., Wallingford J. B.. 1997. Model systems for the study of kidney development: Use of the pronephros in the analysis of organ induction and patterning. Dev. Biol.. 188: 189–204. [PUBMED], [INFOTRIEVE]
- Smith C., Mackay S.. 1991. Morphological development and fate of the mouse mesonephros. J. Anat.. 174: 171–184. [PUBMED], [INFOTRIEVE]
- Vainio S., Heikkila M., Kispert A., Chin N., McMahon A. P.. 1999. Female development in mammals is regulated by Wnt-4 signalling. Nature. 397: 405–409. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pohl M., Bhatnagar V., Mendoza S. A., Nigam S. K.. 2002. Toward an etiological classification of developmental disorders of the kidney and upper urinary tract. Kidney Int.. 61: 10–19. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pohl M., Stuart R. O., Sakurai H., Nigam S. K.. 2000. Branching morphogenesis during kidney development. Ann. Rev. Physiol.. 62: 595–620. [CROSSREF]
- Vainio S., Muller U.. 1997. Inductive tissue interactions, cell signaling, and the control of kidney organogenesis. Cell. 90: 975–978. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Schedl A., Hastie N. D.. 2000. Cross-talk in kidney development. Curr. Opin. Genet. Dev.. 10: 543–549. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Robert B., Abrahamson D. R.. 2001. Control of glomerular capillary development by growth factor/receptor kinases. Pediatr. Nephrol.. 16: 294–301. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Grobstein C., Cohen J.. 1965. Collagenase: Effect on the morphogenesis of embryonic salivary epithelium in vitro. Science. 150: 626–628. [PUBMED], [INFOTRIEVE]
- Perantoni A. O., Dove L. F., Karavanova I.. 1995. Basic fibroblast growth factor can mediate the early inductive events in renal development. Proc. Natl. Acad. Sci. USA. 92: 4696–4700. [PUBMED], [INFOTRIEVE], [CSA]
- Karavanova I. D., Dove L. F., Resau J. H., Perantoni A. O.. 1996. Conditioned medium from a rat ureteric bud cell line in combination with bFGF induces complete differentiation of isolated metanephric mesenchyme. Development. 122: 4159–4167. [PUBMED], [INFOTRIEVE]
- Kanwar Y. S., Carone F. A., Kumar A., Wada J., Ota K., Wallner E. I.. 1997. Role of extracellular matrix, growth factors and proto-oncogenes in metanephric development. Kidney Int.. 52: 589–606. [PUBMED], [INFOTRIEVE]
- Wallner E. I., Yang Q., Peterson D. R., Wada J., Kanwar Y. S.. 1998. Relevance of extracellular matrix, its receptors, and cell adhesion molecules in mammalian nephrogenesis. Am. J. Physiol.. 275: F467–477. [PUBMED], [INFOTRIEVE]
- Wallner E. I., Kumar A., Carone F. A., Kanwar Y. S.. 1998. Growth factors in metanephric development. Ren. Fail.. 20: 331–341. [PUBMED], [INFOTRIEVE], [CSA]
- Wada J., Kanwar Y. S., Makino H.. 2002. Relevance of extracellular matrix and its receptors in mammalian nephrogenesis revealed by metanephric organ culture system. Nephrol. Dial. Transplant.. 17(Suppl 9)75–77. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ruoslahti E., Yamaguchi Y.. 1991. Proteoglycans as modulators of growth factor activities. Cell. 64: 867–869. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Adamson E. D.. 1993. Growth factors and their receptors in development. Dev. Genet.. 14: 159–164. [PUBMED], [INFOTRIEVE]
- Affolter M., Bellusci S., Itoh N., Shilo B., Thiery J. P., Werb Z.. 2003. Tube or not tube: Remodeling epithelial tissues by branching morphogenesis. Dev. Cell. 4: 11–18. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fukuda Y., Masuda Y., Kishi J., Hashimoto Y., Hayakawa T., Nogawa H., Nakanishi Y.. 1988. The role of interstitial collagens in cleft formation of mouse embryonic submandibular gland during initial branching. Development. 103: 259–267. [PUBMED], [INFOTRIEVE]
- Hayakawa T., Kishi J., Nakanishi Y.. 1992. Salivary gland morphogenesis: Possible involvement of collagenase. Matrix Suppl.. 1: 344–351. [PUBMED], [INFOTRIEVE]
- Nakanishi Y., Sugiura F., Kishi J., Hayakawa T.. 1986. Collagenase inhibitor stimulates cleft formation during early morphogenesis of mouse salivary gland. Dev. Biol.. 113: 201–206. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Reponen P., Leivo I., Sahlberg C., Apte S. S., Olsen B. R., Thesleff I., Tryggvason K.. 1995. 92-kDa type IV collagenase and TIMP-3, but not 72-kDa type IV collagenase or TIMP-1 or TIMP-2, are highly expressed during mouse embryo implantation. Dev. Dyn.. 202: 388–396. [PUBMED], [INFOTRIEVE], [CSA]
- Sympson C. J., Talhouk R. S., Alexander C. M., Chin J. R., Clift S. M., Bissell M. J., Werb Z.. 1994. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol.. 125: 681–693. [PUBMED], [INFOTRIEVE], [CROSSREF]
- D'Armiento J., Dalal S. S., Okada Y., Berg R. A., Chada K.. 1992. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell. 71: 955–961. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ganser G. L., Stricklin G. P., Matrisian L. M.. 1991. EGF and TGF alpha influence in vitro lung development by the induction of matrix-degrading metalloproteinases. Int. J. Dev. Biol.. 35: 453–461. [PUBMED], [INFOTRIEVE]
- Legallicier B., Trugnan G., Murphy G., Lelongt B., Ronco P.. 2001. Expression of the type IV collagenase system during mouse kidney development and tubule segmentation. J. Am. Soc. Nephrol.. 12: 2358–2369. [PUBMED], [INFOTRIEVE], [CSA]
- Lelongt B., Trugnan G., Murphy G., Ronco P. M.. 1997. Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J. Cell Biol.. 136: 1363–1373. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tanney D. C., Feng L., Pollock A. S., Lovett D. H.. 1998. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis. Dev. Dyn.. 213: 121–129. [PUBMED], [INFOTRIEVE], [CSA]
- Lelongt B., Legallicier B., Piedagnel R., Ronco P. M.. 2001. Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases?. Curr. Opin. Nephrol. Hypertens.. 10: 7–12. [PUBMED], [INFOTRIEVE], [CSA]
- Barasch J., Yang J., Qiao J., Tempst P., Erdjument-Bromage H., Leung W., Oliver J. A.. 1999. Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. J. Clin. Invest.. 103: 1299–1307. [PUBMED], [INFOTRIEVE], [CSA]
- Pavlova A., Stuart R. O., Pohl M., Nigam S. K.. 1999. Evolution of gene expression patterns in a model of branching morphogenesis. Am. J. Physiol.. 277: F650–663. [PUBMED], [INFOTRIEVE]
- Cheng S., Lovett D. H.. 2003. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am. J. Pathol.. 162: 1937–1949. [PUBMED], [INFOTRIEVE]
- Kadono Y., Shibahara K., Namiki M., Watanabe Y., Seiki M., Sato H.. 1998. Membrane type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in madin-darby canine kidney epithelial cells. Biochem. Biophys. Res. Commun.. 251: 681–687. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kadono Y., Okada Y., Namiki M., Seiki M., Sato H.. 1998. Transformation of epithelial Madin-Darby canine kidney cells with p60(v-src) induces expression of membrane-type 1 matrix metalloproteinase and invasiveness. Cancer Res.. 58: 2240–2244. [PUBMED], [INFOTRIEVE]
- Yu Q., Stamenkovic I.. 2000. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev.. 14: 163–176. [PUBMED], [INFOTRIEVE]
- Umeda Y., Miyazaki Y., Shiinoki H., Higashiyama S., Nakanishi Y., Hieda Y.. 2001. Involvement of heparin-binding EGF-like growth factor and its processing by metalloproteinases in early epithelial morphogenesis of the submandibular gland. Dev. Biol.. 237: 202–211. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sakurai H., Nigam S. K.. 1997. Transforming growth factor-beta selectively inhibits branching morphogenesis but not tubulogenesis. Am. J. Physiol.. 272: F139–146. [PUBMED], [INFOTRIEVE]
- Castagnino P., Soriano J. V., Montesano R., Bottaro D. P.. 1998. Induction of tissue inhibitor of metalloproteinases-3 is a delayed early cellular response to hepatocyte growth factor. Oncogene. 17: 481–492. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dunsmore S. E., Rubin J. S., Kovacs S. O., Chedid M., Parks W. C., Welgus H. G.. 1996. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J. Biol. Chem.. 271: 24576–24582. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sappino A. P., Huarte J., Vassalli J. D., Belin D.. 1991. Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J. Clin. Invest.. 87: 962–970. [PUBMED], [INFOTRIEVE]
- Pepper M. S., Matsumoto K., Nakamura T., Orci L., Montesano R.. 1992. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J. Biol. Chem.. 267: 20493–20496. [PUBMED], [INFOTRIEVE]
- Carmeliet P., Schoonjans L., Kieckens L., Ream B., Degen J., Bronson R., De, Vos R., van den, Oord J. J., Collen D., Mulligan R. C.. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 368: 419–424. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Piedagnel R., Murphy G., Ronco P. M., Lelongt B.. 1999. Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor. J. Biol. Chem.. 274: 1614–1620. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Itoh T., Ikeda T., Gomi H., Nakao S., Suzuki T., Itohara S.. 1997. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem.. 272: 22389–22392. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lelongt B., Bengatta S., Delauche M., Lund L. R., Werb Z., Ronco P. M.. 2001. Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity. J. Exp. Med.. 193: 793–802. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lelongt B., Ronco P.. 2002. Role of matrix metalloproteinases in kidney development and glomerulopathy: Lessons from transgenic mice. Nephrol. Dial. Transplant.. 17 Suppl, 9: 28–31. [CROSSREF]
- Andrews K. L., Betsuyaku T., Rogers S., Shipley J. M., Senior R. M., Miner J. H.. 2000. Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome. Am. J. Pathol.. 157: 303–311. [PUBMED], [INFOTRIEVE]
- Reponen P., Sahlberg C., Munaut C., Thesleff I., Tryggvason K.. 1994. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J. Cell Biol.. 124: 1091–1102. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov S. A., Mankani M., Robey P. G., Poole A. R., Pidoux I., Ward J. M., Birkedal-Hansen H.. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 99: 81–92. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Zhou Z., Apte S. S., Soininen R., Cao R., Baaklini G. Y., Rauser R. W., Wang J., Cao Y., Tryggvason K.. 2000. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. USA. 97: 4052–4057. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kinoh H., Sato H., Tsunezuka Y., Takino T., Kawashima A., Okada Y., Seiki M.. 1996. MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J. Cell Sci.. 109(Pt 5)953–959. [PUBMED], [INFOTRIEVE]
- Hiraoka N., Allen E., Apel I. J., Gyetko M. R., Weiss S. J.. 1998. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell. 95: 365–377. [PUBMED], [INFOTRIEVE]
- Martignetti J. A., Aqeel A. A., Sewairi W. A., Boumah C. E., Kambouris M., Mayouf S. A., Sheth K. V., Eid W. A., Dowling O., Harris J., Glucksman M. J., Bahabri S., Meyer B. F., Desnick R. J.. 2001. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat. Genet.. 28: 261–265. [PUBMED], [INFOTRIEVE]
- Carome M. A., Striker L. J., Peten E. P., Elliot S. J., Yang C. W., Stetler-Stevenson W. G., Reponen P., Tryggvason K., Striker G. E.. 1994. Assessment of 72-kilodalton gelatinase and TIMP-1 gene expression in normal and sclerotic murine glomeruli. J. Am. Soc. Nephrol.. 5: 1391–1399. [PUBMED], [INFOTRIEVE], [CSA]
- Caterina J. J., Yamada S., Caterina N. C., Longenecker G., Holmback K., Shi J., Yermovsky A. E., Engler J. A., Birkedal-Hansen H.. 2000. Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation. J. Biol. Chem.. 275: 26416–26422. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kinoshita T., Sato H., Okada A., Ohuchi E., Imai K., Okada Y., Seiki M.. 1998. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J. Biol. Chem.. 273: 16098–16103. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Corcoran M. L., Kleiner D. E., Jr., Stetler-Stevenson W. G.. 1995. Regulation of matrix metalloproteinases during extracellular matrix turnover. Adv. Exp. Med. Biol.. 385: 151–159. [PUBMED], [INFOTRIEVE], [CSA]
- Seo D-W., Li H., Guedez L., Wingfield P. T., Diaz T., Salloum R., Wei B.-Y., Stetler-Stevenson W. G.. 2003. TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism. Cell. 114: 171–180. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kanwar Y. S., Wada J., Lin S., Danesh F. R., Chugh S. S., Yang Q., Banerjee T., Lomasney J. W.. 2004. Update of extracellular matrix, its receptors, and cell adhesion molecules in mammalian nephrogenesis. Am. J. Physiol. 286: F202–F215. [CSA]
- Koseki C., Herzlinger D., Al-Awqati Q.. 1992. Apoptosis in metanephric development. J. Cell Biol.. 119: 1327–1333. [PUBMED], [INFOTRIEVE], [CROSSREF]